High Free Cash Flow Stocks
SNN is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
SMITH & NEPHEW PLC -SPON ADR (SNN) Stock Price & Overview
NYSE:SNN • US83175M2052
Current stock price
32.14 USD
+0.05 (+0.16%)
At close:
32.14 USD
0 (0%)
After Hours:
The current stock price of SNN is 32.14 USD. Today SNN is up by 0.16%. In the past month the price decreased by -7.78%. In the past year, price increased by 22.16%.
SNN Key Statistics
52-Week Range23.91 - 38.79
Current SNN stock price positioned within its 52-week range.
1-Month Range31.21 - 34.83
Current SNN stock price positioned within its 1-month range.
- Market Cap
- 13.643B
- P/E
- 22.01
- Fwd P/E
- 13.10
- EPS (TTM)
- 1.46
- Dividend Yield
- 2.46%
SNN Stock Performance
Today
+0.16%
1 Week
-0.40%
1 Month
-7.78%
3 Months
-2.25%
Longer-term
6 Months -11.51%
1 Year +22.16%
2 Years +33.20%
3 Years -1.71%
5 Years -25.55%
10 Years -6.38%
SNN Stock Chart
SNN Stock Screens
SNN currently appears in the following ChartMill screener lists.
Value Stocks with Strong Balance Sheets
SNN is currently part of our value stocks with Strong Balance Sheets screen, indicating it cheap while meeting strict financial health and debt criteria.
SNN Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to SNN. When comparing the yearly performance of all stocks, SNN turns out to be only a medium performer in the overall market: it outperformed 57.58% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
SNN Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SNN. While SNN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
SNN Earnings
Next Earnings DateMay 6, 2026
Last Earnings DateMar 2, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
SNN Forecast & Estimates
24 analysts have analysed SNN and the average price target is 39.35 USD. This implies a price increase of 22.45% is expected in the next year compared to the current price of 32.14.
For the next year, analysts expect an EPS growth of 13.3% and a revenue growth 5.58% for SNN
Analysts
Analysts75.83
Price Target39.35 (22.43%)
EPS Next Y13.3%
Revenue Next Year5.58%
SNN Groups
Sector & Classification
SNN Financial Highlights
Over the last trailing twelve months SNN reported a non-GAAP Earnings per Share(EPS) of 1.46. The EPS increased by 52.3% compared to the year before.
Income Statements
Revenue(TTM)6.16B
Net Income(TTM)625.00M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.14% | ||
| ROA | 5.98% | ||
| ROE | 11.82% | ||
| Debt/Equity | 0.62 |
Chartmill High Growth Momentum
EPS Q2Q%70.1%
Sales Q2Q%7.38%
EPS 1Y (TTM)52.3%
Revenue 1Y (TTM)6.09%
SNN Ownership
Ownership
Inst Owners71.25%
Shares424.49M
Float423.76M
Ins Owners0.11%
Short Float %0.83%
Short Ratio4.04
SNN Latest News, Press Relases and Analysis
a day ago - By: Chartmill
SNN Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.91 | 178.754B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.23 | 160.562B | ||
| SYK | STRYKER CORP | 21.92 | 126.877B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.96 | 93.218B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.9 | 47.074B | ||
| IDXX | IDEXX LABORATORIES INC | 38.42 | 45.348B | ||
| BDX | BECTON DICKINSON AND CO | 11.33 | 43.995B | ||
| RMD | RESMED INC | 18.25 | 32.645B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.61 | 32.062B | ||
| DXCM | DEXCOM INC | 24.47 | 23.946B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.72 | 17.783B | ||
| HOLX | HOLOGIC INC | 15.41 | 16.888B | ||
| PODD | INSULET CORP | 31.6 | 14.383B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SNN
Company Profile
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 16,988 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Company Info
IPO: 1951-08-13
SMITH & NEPHEW PLC -SPON ADR
Building 5, Croxley Park, Hatters Lane
Watford HERTFORDSHIRE WD18 8YE GB
CEO: Roland Diggelmann
Employees: 16988
Phone: 4401923477100
SMITH & NEPHEW PLC -SPON ADR / SNN FAQ
Can you describe the business of SMITH & NEPHEW PLC -SPON ADR?
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 16,988 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Can you provide the latest stock price for SMITH & NEPHEW PLC -SPON ADR?
The current stock price of SNN is 32.14 USD. The price increased by 0.16% in the last trading session.
Does SMITH & NEPHEW PLC -SPON ADR pay dividends?
SMITH & NEPHEW PLC -SPON ADR (SNN) has a dividend yield of 2.46%. The yearly dividend amount is currently 0.38.
How is the ChartMill rating for SMITH & NEPHEW PLC -SPON ADR?
SNN has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the valuation of SMITH & NEPHEW PLC -SPON ADR (SNN) based on its PE ratio?
The PE ratio for SMITH & NEPHEW PLC -SPON ADR (SNN) is 22.01. This is based on the reported non-GAAP earnings per share of 1.46 and the current share price of 32.14 USD.
When is the next dividend date for SMITH & NEPHEW PLC -SPON ADR (SNN)?
The next ex-dividend date for SMITH & NEPHEW PLC -SPON ADR (SNN) is March 27, 2026.
Can you provide the ownership details for SNN stock?
You can find the ownership structure of SMITH & NEPHEW PLC -SPON ADR (SNN) on the Ownership tab.